Natco Pharma Ltd Quarterly Results
Q4 FY25-26 Results Summary
Revenue
The revenue stands at ₹739.10 crore, reflecting a quarter-on-quarter *(QoQ) increase of 14.18 per cent from ₹647.30 crore. This corresponds to a year-on-year *(YoY) decline of 39.47 per cent.
Operating Profit
Operating Profit stands at ₹127.60 crore, reflecting a quarter-on-quarter *(QoQ) decrease of 19.60 per cent from ₹158.70 crore. This corresponds to a year-on-year *(YoY) decline of 76.72 per cent.
PBDT
PBDT stands at ₹230.20 crore, reflecting a quarter-on-quarter *(QoQ) increase of 5.50 per cent from ₹218.20 crore. This corresponds to a year-on-year *(YoY) decline of 61.90 per cent.
Profit Before Tax
Profit Before Tax stands at ₹179.80 crore, reflecting a quarter-on-quarter *(QoQ) increase of 4.53 per cent from ₹172.00 crore. This corresponds to a year-on-year *(YoY) decline of 64.46 per cent.
Net Profit
Net Profit stands at ₹269.00 crore, reflecting a quarter-on-quarter *(QoQ) increase of 77.79 per cent from ₹151.30 crore. This represents a 33.74 per cent year-on-year *(YoY) decline for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Natco Pharma Ltd News
Natco Pharma Ltd Earnings
- YOY
- QOQ
Natco Pharma Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Natco Pharma Ltd Research Reports
Natco Pharma Ltd Financial Reports
Natco Pharma Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Natco Pharma | -2.90% | -3.47% | 4.40% | -12.96% | 12.08% | -9.91% |
| Astrazeneca Phar | -1.04% | -1.04% | -5.82% | -5.22% | -3.59% | -10.56% |
| Caplin Point Lab | -4.63% | -6.61% | 0.11% | 41.12% | 44.93% | 18.50% |
| OneSource Speci. | 0.10% | 0.13% | 5.28% | -6.70% | 15.17% | -17.43% |
| Cohance Life | -2.53% | -1.74% | -5.03% | 19.55% | 14.05% | -58.39% |
| Alembic Pharma | -2.19% | -3.02% | 5.07% | 6.00% | 7.00% | -20.18% |
| Jubilant Pharmo | -1.11% | -3.50% | 1.15% | 4.03% | 3.12% | -17.79% |
Company Info
Company Information
Chairman / Executive Director / M D / Promoter : V C Nannapaneni
Vice Chairman & Chief Executive Officer : Rajeev Nannapaneni
ED / EVP : PSRK Prasad
ED / President : D Linga Rao
Independent Non Exe. Director : A D Murthy Chavali
Independent Non Exe. Director : Vijayabhaskar Dronadula
Independent Non Exe. Director : B. Lakshminarayana
Independent Non Exe. Director : Kantipudi Suma
Independent Non Exe. Director : Nitin Jain
Company Sec. & Compli. Officer : Chekuri Venkat Ramesh